Research programme: cognitive disorders therapeutics - Cenomed BioSciences
Alternative Names: CB-2,433; CM-2,433; CM-2,450Latest Information Update: 04 Nov 2017
Price :
$50 *
At a glance
- Originator Medical College of Georgia
- Class Small molecules
- Mechanism of Action Cholinergic receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease; Mild cognitive impairment